Huong Nguyen, Elizabeth Crompton Co-Author 2nd Edition of Pre-ANDA Litigation Book Chapters
Haynes and Boone, LLP Counsel Huong Nguyen and Associate Elizabeth Crompton co-authored two chapters in the recently published Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, Second Edition. They were also associate editors of the book.
Published by the American Bar Association, the updated book serves as a resource for lawyers planning Abbreviated New Drug Application (ANDA) litigations and strategizing for patent litigation on behalf of pharmaceutical companies.
Topics in the book include:
-Coordinating new drug application (NDA) and patent portfolio strategy
-Preclinical and patent considerations
-Clinical trials and regulatory considerations
-Trademark (TM) and nonproprietary name considerations
-Acquiring and in-licensing pharmaceutical products
-Pre-litigation investigations and due diligence
-Market entry business considerations for generic companies
To read more about this publication, click here.
Nguyen is counsel in the Intellectual Property Litigation Practice Group in Haynes and Boone’s Palo Alto office. Her practice focuses on the pharmaceutical industry.
Prior to joining Haynes and Boone, Nguyen spent a decade in-house at a specialty pharmaceutical company, where her most recent position was leading its corporate and intellectual property litigation and investigation practice. While in-house, she gained a deep understanding of the business of developing, manufacturing, and selling pharmaceutical drug products. That experience ranges from product adoption, development and filing of applications to the Food and Drug Administration to brand and generic patent litigation and proceedings before the Patent and Trademark Appeals Board, as well as to regulatory approval, marketing, and commercial launch of the drug products.
Crompton is an experienced trial lawyer who uses her advanced education and experience to understand complex technical matters and help clients achieve their goals.
She concentrates on patent disputes before district courts and the Federal Circuit. She also counsels clients on design patents, infringement, validity and enforceability of patents, particularly in the chemical/biological and mechanical areas, including Hatch-Waxman.